Eagle Pharmaceuticals to Present at 2017 RBC Capital Markets Global Healthcare Conference
Public Company Information:
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) announced today that Scott Tarriff, Chief Executive Officer, David Pernock, President and Chief Commercial Officer, and David Riggs, Chief Financial Officer, will present at the 2017 RBC Capital Markets Global Healthcare Conference as follows:
|Date:||Wednesday, February 22, 2017|
|Time:||3:35 p.m. Eastern Standard Time|
|Location:||The New York Palace Hotel|
The presentation will be webcast live at the aforementioned time, and archived for 90 days thereafter, via the company’s website at www.eagleus.com, under the Investors Section and is also available at http://www.veracast.com/webcasts/rbc/healthcare2017/97114205455.cfm.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the company’s website at www.eagleus.com.